Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. M. Lucena, M. Rovira, X. Filella, R. Domingo, A. Torres, C. Agustí (Barcelona, Spain). Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplant. Eur Respir J 2013; 42: Suppl. 57, 4400

Member's Comments

No comment yet.

Related content which might interest you: Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease Year: 2016 Hypogammaglobulinemia in lung transplant candidates Source: International Congress 2016 – Long-term outcomes of lung transplantation Year: 2016 Evaluation of pulmonary functions after hematopoietic stem cell transplantation in children Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Year: 2015 Timeline of pulmonary complications after hematopoietic stem cell transplantation in children Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017 Year: 2018 Respiratory infections in autologus stem cell transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Noninfectious pulmonary complications of haematopoietic stem cell transplantation Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019 Year: 2020 Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017 Year: 2018 Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Pulmonary function and respiratory complications in hematopoietic cell transplant Source: International Congress 2016 – Quality and quantity in lung function Year: 2016 Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Pulmonary function changes following allogeneic haematopoietic cell transplantation Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Analysis of factors affecting pretransplant pulmonary function tests and impact on overall survival after allogenic stem cell transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019